RESUMO
Tetraferrocenylporphyrins (TFcPs) are a class of compounds where the porphyrin macrocycle is functionalized with a ferrocenyl group at each of the four meso positions. TFcPs exhibit interesting electrochemical properties, mostly due to electronic communication between the ferrocenyl substituents and the porphyrin core. This leads to their capability to release and accept multiple electrons at distinct potentials through reversible and well distinguished processes. Synthesis of substituted-tetraferrocenylporphyrins containing a carboxylic acid functionality allowed to prepare well packed thin layers of TFcP on ITO electrodes using different deposition techniques. In this context, self-assembled monolayers (SAMs) and Langmuir-Blodgett mono- and multilayers (LBs) of TFcPs have been prepared on ITO surfaces. TFcP-functionalized ITO electrodes showed very high stability, and their application in photocatalytic oxygen activation has been tested.
RESUMO
Current state-of-the-art imaging techniques can provide quantitative information to characterize ventricular function within the limits of the spatiotemporal resolution achievable in a realistic acquisition time. These imaging data can be used to personalize computer models, which in turn can help treatment planning by quantifying biomarkers that cannot be directly imaged, such as flow energy, shear stress and pressure gradients. To date, computer models have typically relied on invasive pressure measurements to be made patient-specific. When these data are not available, the scope and validity of the models are limited. To address this problem, we propose a new methodology for modeling patient-specific hemodynamics based exclusively on noninvasive velocity and anatomical data from 3D+t echocardiography or Magnetic Resonance Imaging (MRI). Numerical simulations of the cardiac cycle are driven by the image-derived velocities prescribed at the model boundaries using a penalty method that recovers a physical solution by minimizing the energy imparted to the system. This numerical approach circumvents the mathematical challenges due to the poor conditioning that arises from the imposition of boundary conditions on velocity only. We demonstrate that through this technique we are able to reconstruct given flow fields using Dirichlet only conditions. We also perform a sensitivity analysis to investigate the accuracy of this approach for different images with varying spatiotemporal resolution. Finally, we examine the influence of noise on the computed result, showing robustness to unbiased noise with an average error in the simulated velocity approximately 7% for a typical voxel size of 2mm(3) and temporal resolution of 30ms. The methodology is eventually applied to a patient case to highlight the potential for a direct clinical translation.
Assuntos
Simulação por Computador , Ecocardiografia Tridimensional , Hemodinâmica , Imageamento por Ressonância Magnética , Modelos Cardiovasculares , Função Ventricular , Velocidade do Fluxo Sanguíneo , Humanos , Análise Espaço-TemporalRESUMO
Wilson's disease (WD) is an autosomal recessive disorder characterized by copper overload. In this disease, inadequate hepatic excretion leads to copper accumulation in the liver, brain, kidney, and cornea. Severe neurological symptoms can develop in patients with WD, often in the absence of relevant liver damage: it is unclear whether liver transplantation (LT) could reverse neurological symptoms, and at present LT is not recommended in this setting. We report a case of regression of neurological symptoms in a patient affected by WD with prevalent neurological involvement. A 19-year-old man with disabling neuropsychiatric symptoms from WD that included frontal ataxia, akinesia, dystonia, tremors, and behavioral disorders in the presence of preserved liver function (Model for End-Stage Liver Disease score=7; Child-Turcotte-Pugh score=A5) underwent LT in November 2009. At the time of LT, encephalic magnetic resonance imaging (MRI) indicated diffuse neurodegenerative alterations involving subtentorial and supratentorial structures; bilateral Kayser-Fleischer ring was present. Four years after LT, laboratory tests show normalized copper metabolism and excellent liver function test results. Encephalic MRI shows a substantial improvement of already-known signal alterations at nuclei thalamus and putamen, mesencephalon, and pons. Kayser-Fleischer ring disappeared from the right eye, but a little remnant is still visible in the left eye. At neurological examination, all of the previous symptoms and signs are no longer present and behavioral disorders are no longer present; psychosocial functions are completely restored. The present case provides some evidence that LT may be a valid therapeutic option for WD patients with marked neurological impairment, particularly in those no longer responsive to chelation therapy.
Assuntos
Degeneração Hepatolenticular/cirurgia , Transplante de Fígado , Ceruloplasmina/análise , Cobre/sangue , Degeneração Hepatolenticular/complicações , Degeneração Hepatolenticular/diagnóstico , Humanos , Rim/patologia , Testes de Função Hepática , Imageamento por Ressonância Magnética , Masculino , Adulto JovemRESUMO
Computer modelling of the heart has emerged over the past decade as a powerful technique to explore the cardiovascular pathophysiology and inform clinical diagnosis. The current state-of-the-art in biophysical modelling requires a wealth of, potentially invasive, clinical data for the parametrisation and validation of the models, a process that is still too long and complex to be compatible with the clinical decision-making time. Therefore, there remains a need for models that can be quickly customised to reconstruct physical processes difficult to measure directly in patients. In this paper, we propose a less resource-intensive approach to modelling, whereby computational fluid-dynamics (CFD) models are constrained exclusively by boundary motion derived from imaging data through a validated wall tracking algorithm. These models are generated and parametrised based solely on ultrasound data, whose acquisition is fast, inexpensive and routine in all patients. To maximise the time and computational efficiency, a semi-automated pipeline is embedded in an image processing workflow to personalise the models. Applying this approach to two patient cases, we demonstrate this tool can be directly used in the clinic to interpret and complement the available clinical data by providing a quantitative indication of clinical markers that cannot be easily derived from imaging, such as pressure gradients and the flow energy.
Assuntos
Velocidade do Fluxo Sanguíneo/fisiologia , Imageamento Tridimensional/métodos , Modelos Cardiovasculares , Contração Miocárdica/fisiologia , Modelagem Computacional Específica para o Paciente , Função Ventricular/fisiologia , Pressão Sanguínea/fisiologia , Simulação por Computador , Humanos , Reologia/métodosRESUMO
Cardiac diseases represent one of the primary causes of mortality and result in a substantial decrease in quality of life. Optimal surgical planning and long-term treatment are crucial for a successful and cost-effective patient care. Recently developed state-of-the-art imaging techniques supply a wealth of detailed data to support diagnosis. This provides the foundations for a novel approach to clinical planning based on personalisation, which can lead to more tailored treatment plans when compared to strategies based on standard population metrics. The goal of this study is to develop and apply a methodology for creating personalised ventricular models of blood and tissue mechanics to assess patient-specific metrics. Fluid-structure interaction simulations are performed to analyse the diastolic function in hypoplastic left heart patients, who underwent the first stage of a three-step surgical palliation and whose condition must be accurately evaluated to plan further intervention. The kinetic energy changes generated by the blood propagation in early diastole are found to reflect the intraventricular pressure gradient, giving indications on the filling efficiency. This suggests good agreement between the 3D model and the Euler equation, which provides a simplified relationship between pressure and kinetic energy and could, therefore, be applied in the clinical context.
Assuntos
Coração/fisiologia , Modelos Cardiovasculares , Medicina de Precisão/métodos , Função Ventricular/fisiologia , Adulto , Algoritmos , Engenharia Biomédica , Simulação por Computador , Ecocardiografia , Coração/fisiopatologia , Ventrículos do Coração/diagnóstico por imagem , Ventrículos do Coração/patologia , Ventrículos do Coração/fisiopatologia , Hemodinâmica/fisiologia , Humanos , Síndrome do Coração Esquerdo Hipoplásico/patologia , Síndrome do Coração Esquerdo Hipoplásico/fisiopatologia , Imageamento Tridimensional , Imageamento por Ressonância MagnéticaRESUMO
The aim of this study was to evaluate penile anthropometry in systemic lupus erythematosus (SLE) patients compared with healthy controls and the possible relevant pubertal, clinical, hormonal and treatment factors that could influence penile dimensions. Twenty-five consecutive SLE patients were assessed by urological examination, sexual function, testicular ultrasound, hormones, sperm analysis, genetic analysis, clinical features and treatment. The control group included 25 age-matched healthy males. SLE patients had a lower median penis length and circumference [8 (7.5-10) vs. 10 (8-13) cm, p = 0.0001; 8 (7-10) vs. 10 (7-11) cm, p = 0.001; respectively], lower median testicular volume by right and left Prader [15 (10-25) vs. 20 (12-25) ml, p = 0.003; 15 (10-25) vs. 20 (12-25) ml, p = 0.006; respectively], higher median of follicle-stimulating hormone [5.8 (2.1-25) vs. 3.3 (1.9-9) IU/l, p = 0.002] and lower morning total testosterone levels (28% vs. 0%, p = 0.009) compared with controls. In spite of that, erectile dysfunction was not observed in patients or controls. Analyses of lupus patients revealed that the median penis circumference was lower in patients with disease onset before first ejaculation compared with those with disease onset after first ejaculation [7.8 (7-10) vs. 9.0 (7.5-10) cm, p = 0.026]. No differences were observed in the median penile anthropometry regarding sexual dysfunction (p = 0.610), lower morning total testosterone levels (p = 0.662), oligo/azoospermia (p = 0.705), SLE Disease Activity Index ≥ 4 (p = 0.562), Systemic Lupus International Collaborating Clinics/ACR Damage Index ≥ 1 (p = 0.478), prednisone cumulative dose (p = 0.789) and intravenous cyclophosphamide therapy (p = 0.754). Klinefelters syndrome (46XY/47XXY) was diagnosed in one (4%) SLE patient with decreased penile size whereas Y-chromosomal microdeletions was absent in all of them. In conclusion, we have identified reduced penile dimensions in SLE patients with no deleterious effect in erectile function. Disease onset before first ejaculation seems to affect penis development in pre-pubertal lupus.
Assuntos
Lúpus Eritematoso Sistêmico/patologia , Pênis/patologia , Adolescente , Adulto , Antropometria , Estudos de Casos e Controles , Humanos , Síndrome de Klinefelter/patologia , Masculino , Tamanho do Órgão , Adulto JovemRESUMO
Antiphospholipid antibodies (aPL) are associated with recurrent miscarriages and pregnancy complications, however their pathogenic mechanisms are still matter of research. Thrombotic events at the placental level cannot explain all of the clinical manifestations. It has been suggested that aPL may be responsible for a local acute inflammatory response mediated by complement activation and neutrophil infiltration eventually leading to fetal loss. However histological and immunohistological studies on human placental samples do support such a mechanism only in part and with no any clear relationship with the pregnancy outcome. A direct effect of aPL on both maternal and fetal placental tissues has been reported through the reactivity of the antibodies with beta2 glycoprotein I (beta2GPI) expressed on the cell membranes. These events do not require an inflammatory response and can be in part related to the inhibition of growth factors favouring a physiological placentation. Understanding the different pathogenic mechanisms of aPL-associated miscarriages may help in improving our therapeutic approach particularly in recurrent cases not responsive to the usual treatment.
Assuntos
Aborto Habitual/imunologia , Anticorpos Antifosfolipídeos/imunologia , Complicações na Gravidez/imunologia , Aborto Habitual/etiologia , Síndrome Antifosfolipídica/complicações , Síndrome Antifosfolipídica/imunologia , Membrana Celular/imunologia , Ativação do Complemento/imunologia , Feminino , Humanos , Inflamação/etiologia , Inflamação/imunologia , Infiltração de Neutrófilos/imunologia , Gravidez , Complicações na Gravidez/etiologia , Trombose/etiologia , Trombose/imunologia , beta 2-Glicoproteína I/imunologiaRESUMO
The indications for organ transplantation continue to broaden with advances in perioperative care and immunosuppression. The elderly have especially benefited from this progress; advanced age is no longer considered a contraindication to transplantation at most centers. Although numerous studies support the use of renal allografts in older patients, only a few centers have addressed this issue as it pertains to liver transplantation. Published studies have revealed that operative course, length of hospitalization, and incidence of perioperative complications among patients older than 60 years of age are comparable with their younger adult counterparts. In our study we analyzed the clinical experiences of two centers with primary cadaveric orthotopic liver transplantations comparing patients older than 63 with patients younger than 40 years of age, suggesting no difference in unadjusted survival with age stratification. Now age cannot be considered to be a contraindication to liver transplantation.
Assuntos
Sobrevivência de Enxerto , Transplante de Fígado , Taxa de Sobrevida , Adulto , Idoso , Feminino , Humanos , MasculinoRESUMO
Renal failure and the need for dialysis worsen the prognosis of patients with combined liver and kidney disease. The choice of an appropriate dialysis technique should improve the life expectancy of these patients. Hypotension, impaired defence against infections, electrolyte and acid-base imbalance, severe protein and caloric malnutrition, hyperammonemia, hyperbilirubinemia, and inadequate response to diuretics present a number of clinical problems in patients with liver insufficiency. Liver failure is therefore considered an important risk factor for any type of dialysis. Theoretically, both hemodialysis and peritoneal dialysis may cause specific problems in these patients. Hemodialysis has an increased cost/benefit ratio in cirrhotic patients. The administration of heparin during dialysis might worsen blood coagulation, ascites is not controlled by hemodialysis, and frequent paracentesis may be necessary. The efficiency of hemodialysis in removing certain toxic substances accumulating in liver failure is still unclear. Peritoneal dialysis does not require anticoagulation, helps maintain residual renal function, allows continuous removal of a fixed amount of ascitic fluid, does not cause acute hemodynamic changes, clears some of the toxic metabolites accumulated by liver failure, and is less expensive. Finally, peritoneal dialysis is associated with continuous absorption of glucose through the mesenteric capillaries into the mesenteric and liver blood flow, thus improving caloric malnutrition. During the first months of peritoneal dialysis, cirrhotic patients lose about 10 g of protein in the peritoneal dialysate but this loss tends to decrease with time. All the available data seem to indicate that in cirrhotic patients on peritoneal dialysis the majority of complications are consequent upon liver disease, which is also the most important cause of death. The outcome of peritoneal dialysis is not affected by cirrhosis and is similar to that observed in noncirrhotic patients. All the evidence reported in the literature seems to indicate that in cirrhotic patients peritoneal dialysis is an adequate treatment of uremia.
Assuntos
Cirrose Hepática/complicações , Diálise Peritoneal , Insuficiência Renal/complicações , Insuficiência Renal/terapia , Humanos , Cirrose Hepática/mortalidade , Cirrose Hepática/terapia , Insuficiência Renal/mortalidade , Taxa de SobrevidaRESUMO
Interferon-gamma-inducible protein 10 is a potent chemoattractant for natural killer cells and activated T lymphocytes. It also displays angiostatic properties and some antitumor activity. Tumor necrosis factor-alpha (TNF-alpha) is a powerful immunomodulating cytokine with demonstrated tumoricidal activity in various tumor models and the ability to induce strong immune responses. This prompted us to evaluate the antitumor effects of recombinant parvoviruses designed to deliver IP-10 or TNF-alpha into a glioblastoma. When Gl261 murine glioma cells were infected in vitro with an IP-10- or TNF-alpha-transducing parvoviral vector and were subcutaneously implanted in mice, tumor growth was significantly delayed. Complete tumor regression was observed when the glioma cells were coinfected with both the vectors, demonstrating synergistic antitumor activity. In an established in vivo glioma model, however, repeated simultaneous peritumoral injection of the IP-10- and TNF-alpha-delivering parvoviruses failed to improve the therapeutic effect as compared with the use of a single cytokine-delivering vector. In this tumor model, cytokine-mediated immunostimulation, rather than inhibition of vascularization, is likely responsible for the therapeutic efficacy.
Assuntos
Quimiocina CXCL10/metabolismo , Quimiocina CXCL10/uso terapêutico , Glioblastoma/tratamento farmacológico , Fator de Necrose Tumoral alfa/metabolismo , Fator de Necrose Tumoral alfa/uso terapêutico , Animais , Quimiocina CXCL10/administração & dosagem , Quimiocina CXCL10/imunologia , Células Dendríticas/citologia , Células Dendríticas/virologia , Sinergismo Farmacológico , Feminino , Vetores Genéticos , Glioblastoma/irrigação sanguínea , Glioblastoma/imunologia , Glioblastoma/metabolismo , Glioblastoma/virologia , Parvovirus H-1/fisiologia , Humanos , Imunocompetência , Camundongos , Camundongos Endogâmicos C57BL , Vírus Miúdo do Camundongo/fisiologia , Necrose/metabolismo , Células Tumorais Cultivadas/citologia , Células Tumorais Cultivadas/efeitos dos fármacos , Fator de Necrose Tumoral alfa/administração & dosagem , Fator de Necrose Tumoral alfa/genéticaRESUMO
The incidence and clinical consequences of hepatic injuries (parenchymal, vascular, and biliary) due to surgical handling during multiorgan procurement are still underestimated. Surgical damage to liver grafts may lead to an increased mortality and graft dysfunction rate; therefore, multiorgan procurements require a high level of expertise and training. We report our experience in two cases of accidental venous outflow damage during liver procurement focusing on our repair strategies. In one case, a short suprahepatic inferior vena cava (IVC) was extended by a venous cuff obtained from a long infrahepatic IVC from the same liver graft. In the second case, we observed a complete transection of the middle hepatic vein during in situ splitting procedure. The damage was reconstructed by cadaveric iliac vein interposition. In both cases, liver transplantation was successfully performed without venous complication. An adequate surgical technique in liver procurement and venous reconstruction during living donor and domino liver transplantation are formidable tools to achieve successful liver transplantation with a damaged graft.
Assuntos
Transplante de Fígado/métodos , Transplante de Fígado/patologia , Fígado/patologia , Obtenção de Tecidos e Órgãos/métodos , Veia Cava Inferior/lesões , Veia Cava Inferior/cirurgia , Cadáver , Humanos , Doadores de Tecidos , Resultado do TratamentoRESUMO
Legal and ethical aspects of withholding or withdrawing dialysis are still matter or debate and it is impossible to present a course of action that would always be correct. Dialysis is an extraordinary, high cost and invasive treatment. Therefore the possibility to withhold or withdraw this treatment should be discussed in each single case, after evaluating comorbidities, expected survival, rehabilitation, quality of life, psychosocial cost and clinical complications. On these basis competent patients have the possibility to give or deny their consent to the treatment and to change this decision at any time. In incompetent patients doctor should try to understand what the patient would choose if he were competent or help family to decide what action would achieve the best interest of the patient. The Catholic Church considers it acceptable to withdraw or withhold extraordinary therapies whose final effect is a mere prolongation of survival with an unacceptably poor quality of life (no apparent therapeutic benefit). It is often inhumane to ask the family to decide to let a patient die. This should be a medical proposal to be accepted by the family after an appropriate information on possible alternatives. Finally palliative care and medical and social assistance should be provided to help the patient and his family.
Assuntos
Consentimento Livre e Esclarecido , Falência Renal Crônica/terapia , Diálise Renal/ética , Eutanásia Passiva , Humanos , Cuidados Paliativos , Participação do Paciente , Suspensão de TratamentoRESUMO
Evaluation of peritoneal catheters is based on the material, the number and type of cuffs, the length and intraperitoneal shape of the catheter, and its site of insertion. Final cost is another important issue which should take into account differences in the incidence of complications, in the number of hospitalizations, and in the simplicity of catheter insertion. Double-cuff catheters are used more than single-cuff catheters. The most commonly used catheter shapes are the classical Tenckhoff, the swan neck, the coil, and self-locating catheters. The latter are more expensive than Tenckhoff catheters but seem to offer some advantages, even if not sustained by adequate controlled trials so far. In addition, placement of these catheters may require different techniques or skills compared to the classical Tenckhoff. The most recent Italian guidelines based only on grade 1 and 2 evidence exclude that the type of catheter may influence the infection rate. There are no data from prospective controlled studies to evaluate the incidence of mechanical complications, hospitalization and technique survival. With regard to dialysis systems, it is still unclear if new plastic materials may offer any advantage over PVC. There is grade 1 evidence that Y-set and double-bag systems reduce the peritonitis rate compared to standard 1-way systems. The available data do not indicate significant differences in the incidence of peritonitis using Y-set compared with double-bag systems. The higher cost of double-bag systems is counteracted by shorter and easier training and by better acceptance by the patients.
Assuntos
Cateterismo , Diálise Peritoneal/instrumentação , Humanos , PeritônioRESUMO
Sarcomas are rare neoplasms, accounting for a 1.7% incidence among all transplanted patients presenting with de novo malignancies. Our present report focused on a 46-year-old woman who received immunosuppressive therapy based on cyclosporine and steroids for renal transplantation. Eight years after transplantations, she suffered lower abdominal pain and a mass involving peritoneal soft tissues was located near the right iliac vessels. Upon radical tumor excision, the histological examination revealed a high-grade leiomyosarcoma. Immunosuppression was reduced and cyclosporine switched to rapamycin. After 30 days, a computed tomography scan revealed two small pulmonary metastases, so the patient received adriamycin. Six months after the diagnosis, there was no intra-abdominal relapse and the pulmonary metastasis remain stable. The function of the transplanted kidney was normal and the patient was listed for laparoscopic pulmonary resection. Sarcomas in solid organ transplant patients appear to have aggressive features with 62% being high grade and 40% metastatic at the time of primary diagnosis with a recurrence rate of 30% and a 5-year survival rate of 25%. Patients diagnosed with sarcoma should be treated with multimodality therapy. After aggressive surgery whenever possible, a combination of a traditional cytotoxic drug and a "signal" blocking agent like rapamycin may increase selectivity toward tumor cells.
Assuntos
Transplante de Rim , Leiomiossarcoma/diagnóstico , Neoplasias Peritoneais/diagnóstico , Sirolimo/uso terapêutico , Feminino , Humanos , Imunossupressores/uso terapêutico , Leiomiossarcoma/diagnóstico por imagem , Neoplasias Pulmonares/patologia , Pessoa de Meia-Idade , Metástase Neoplásica , Neoplasias Peritoneais/diagnóstico por imagem , Complicações Pós-Operatórias/diagnóstico , Complicações Pós-Operatórias/diagnóstico por imagem , Tomografia Computadorizada por Raios XRESUMO
BACKGROUND: The current 3rd edition of the Italian Society of Nephrology guidelines has been drawn up to summarize evidence of key intervention issues on the basis of systematic reviews (SR) of randomized trials (RCT) or RCT data only. The present guideline reports evidence of the use of antimicrobial agents for preventing peritonitis in peritoneal dialysis (PD). METHODS: SR of RCT and RCT on treatments aiming at preventing peritoneal dialysis peritonitis were identified referring to a Cochrane Library and Renal Health Library search (2005 update). Quality of SR and RCT was assessed according to current methodological standards. RESULTS: One SR and 19 RCT were found addressing this issue. Staphylococcus Aureus nasal carriage treatment with mupirocin reduces exit-site and tunnel infections but not peritonitis. Topical gentamicin treatment on the exit site reduces Staphylococcus Aureus infection and peritonitis incidence. Intravenous antibiotics administration prior to catheter placement significantly reduces the risk of early peritonitis but not exit-site and tunnel infections. Oral nistatin associated with antibiotic treatment significantly reduces the incidence of Candida peritonitis. No other prophylaxis measure seems to be effective based on available evidence. CONCLUSION: In patients on peritoneal dialysis current evidence supports the hypothesis that topical mupirocin reduces the risk of Staphylococcus Aureus peritonitis, intravenous antibiotics prior to catheter placement prevent the risk of early peritonitis, and oral nistatin reduces the risk of Candida peritonitis. Further studies are necessary to test the effectiveness of other interventions.
Assuntos
Anti-Infecciosos/uso terapêutico , Diálise Peritoneal , Peritonite/microbiologia , Peritonite/prevenção & controle , Infecções Estafilocócicas/prevenção & controle , HumanosRESUMO
BACKGROUND: The current 3rd edition of the Italian Society of Nephrology guidelines has been drawn up to summarize evidence of key intervention issues on the basis of systematic reviews (SR) of randomized trials (RCT) or RCT data only. The present guideline report evidence of catheter-related interventions to prevent peritonitis in peritoneal dialysis (PD). METHODS: SR of RCT and RCT of catheter-related interventions to prevent peritonitis in PD were identified referring to a Cochrane Library and Renal Health Library search (2005 update). RESULTS: Two SR and 17 RCT were found addressing this issue. Methodological quality of available RCT was suboptimal according to current methodological standards. The use of the Y-set systems with disinfectant and the twin-bag systems was associated with a significantly lower risk of peritonitis. No other catheter-related interventions were found to be of proven efficacy in preventing the risk of peritonitis and exit-site/tunnel infection in PD patients. CONCLUSION: It is still unknown whether any particular PD catheter design or implantation technique are effective to prevent peritonitis in patients on peritoneal dialysis. Further studies are necessary to test the effectiveness of new interventions.
Assuntos
Catéteres , Diálise Peritoneal/instrumentação , Peritonite/prevenção & controle , HumanosRESUMO
BACKGROUND: The current 3rd edition of the Italian Society of Nephrology guidelines has been drawn up to summarize evidence of key intervention issues on the basis of systematic reviews (SR) of randomized trials (RCT) or RCT data only. The present guideline reports evidence of interventions to treat peritonitis in peritoneal dialysis (PD). METHODS: SR of RCT and RCT on treatments for peritoneal dialysis peritonitis were identified referring to a Cochrane Library and Renal Health Library search (2005 update). Quality of SR and RCT was assessed according to current methodological standards. RESULTS: Thirty-six RCT were found addressing the intervention issue. Vancomycin or first generation cephalosporins may be used for treating peritoneal dialysis peritonitis due to Gram-positive agents. Third-generation cephalosporins or amino-glycosides may be used for Gram-negative agents peritonitis. Association of first-generation cephalosporins and agents against Gram-negative bacteria via the intraperitoneal route represents the most frequently used approach. Intraperitoneal administration of antibiotic agents is the most effective treatment of peritoneal dialysis peritonitis. Intermittent administration may be preferred to continuous administration of antibiotic agents in peritoneal dialysis peritonitis. CONCLUSION: In peritoneal dialysis peritonitis current evidence supports the hypothesis that intraperitoneal administration of antibiotics agents and intermittent administration may be preferred to other routes of administration and continuous administration. Further studies are necessary to test this hypothesis in selected patient populations.
Assuntos
Antibacterianos/administração & dosagem , Diálise Peritoneal , Peritonite/diagnóstico , Peritonite/tratamento farmacológico , Humanos , Peritonite/microbiologiaRESUMO
BACKGROUND: Numerous investigations have reported that viral hepatitis is associated with significant hepatocellular damage, as expressed by raised aminotransferases in serum, in dialysis population. However, scarce information exists on the activity of gamma glutamyltranspeptidase (GGTP) in dialysis patients with infection by hepatotropic viruses. OBJECTIVES: We measured serum GGTP values in a large cohort (n=757) of patients receiving long-term dialysis; healthy controls were also included. The relationship between GGTP values and a series of demographic, clinical, and biochemical parameters was analyzed. METHODS: Serum GGTP levels were tested by spectrophotometry. A subset (n=333) of dialysis patients was tested by molecular technology (branched-chain DNA (bDNA) assay) to evaluate the relationship between serum GGTP and HCV viremia. A subgroup (n=78) of dialysis patients was analyzed by an ultrasound scan of gallbladder and biliary tract to assess the presence of gallstone disease. Multivariate analyses were made using regression models; serum GGTP values were included as a dependent variable. The usefulness of serum GGTP levels in detecting HBsAg and anti-HCV positivity was evaluated using receiver operating characteristics (ROC) curve analysis. RESULTS: Univariate analysis showed that serum GGTP levels were significantly higher in HBsAg positive and/or anti-HCV positive patients than in HBsAg negative/anti-HCV negative patients on dialysis; 85.1+/-184.1 versus 25.86+/-23.9 IU/l (P=0.0001). The frequency of raised GGTP levels was 22.2% (41/184) among dialysis patients with chronic viral hepatitis. Multivariate analysis showed a significant and independent association between serum GGTP values and positive HBsAg (P=0.005) and anti-HCV antibody (P=0.0001) status. Mean GGTP values were significantly higher in study patients than controls, 32.32+/-60.02 versus 23.5+/-16.92 IU/L (P=0.01); however, no significant difference with regard to GGTP between study and healthy cohorts persisted after correction for age, gender, race, and viral markers. No relationship between gallstone disease and serum GGTP was found (NS). An independent and significant association (P=0.0291) between raised GGTP levels and detectable HCV RNA in serum was noted among patients tested by biology molecular techniques. ROC technology demonstrated that GGTP was equally useful for detecting HBV (P=0.0004) and HCV (P=0.0005) among dialysis patients. CONCLUSIONS: We found an independent and significant association between serum GGTP values and HBsAg and/or anti-HCV antibody in dialysis population. Twenty-two percent of dialysis patients with chronic viral hepatitis had elevated GGTP. No difference in GGTP between HBsAg- negative/anti-HCV- negative dialysis patients and healthy individuals was found. Routine testing for serum GGTP levels to assess liver disease induced by hepatotropic viruses or other agents in dialysis population is suggested.
Assuntos
Hepatite B/diagnóstico , Hepatite C/diagnóstico , Diálise Renal , gama-Glutamiltransferase/sangue , Adulto , Idoso , Alanina Transaminase/sangue , Aspartato Aminotransferases/sangue , Biomarcadores/sangue , Feminino , Hepatite B/etiologia , Antígenos de Superfície da Hepatite B/sangue , Hepatite C/etiologia , Anticorpos Anti-Hepatite C/sangue , Humanos , Masculino , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Curva ROC , Sensibilidade e EspecificidadeRESUMO
Other than signalling receptors sustaining leucocyte recruitment during inflammatory reactions, the chemokine system includes 'silent' receptors with distinct specificity and tissue distribution. The best-characterized molecule of this subgroup is the CC chemokine receptor D6, which binds most inflammatory CC chemokines and targets them to degradation via constitutive ligand-independent internalization. Structure-function analysis and recent results with gene-targeted animals indicate that D6 has unique functional and structural features, which make it ideally adapted to act as a chemokine decoy and scavenger receptor, strategically located on lymphatic endothelium and placenta to dampen inflammation in tissues and draining lymph nodes.